CT26-hCD24/hPDL1
品系基本信息
驗(yàn)證數(shù)據(jù)
Ⅰ.In vitro?Expression of CT26-hCD24/hPDL1 cell line
Figure 1. hCD24 and hPDL1 expression in CT26-hCD24/hPDL1 cell line
Ⅱ.Characterization of in vivo?growth kinetics
To test the take rates, and the tumor growth characteristics of CT26-hCD24/hPDL1 cell line, cells were subcutaneously inoculated into the Balb/c mice.
Figure 2. Tumor growth curve of CT26-hCD24/hPDL1 syngeneic model
Figure 3. Body weight change of CT26-hCD24/hPDL1 syngeneic model
Ⅲ.Expression of hCD24 and hPDL1 protein in tumors
Figure 4. The expression of hCD24 and hPDL1 in humanized modified tumors by FACS
你也可能感興趣
Cre-ERT2在無Tamoxifen誘導(dǎo)的情況下，在細(xì)胞質(zhì)內(nèi)處于無活性狀態(tài)；當(dāng)Tamoxifen誘導(dǎo)后，Tamoxifen的代謝產(chǎn)物4-OHT（雌激素類似物）與ERT結(jié)合，可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看常見的基因工程小鼠可以分為兩種命名方式，包括基因定點(diǎn)修飾的小鼠命名，比如：敲除、敲入、點(diǎn)突變等等，和隨機(jī)轉(zhuǎn)基因的小鼠命名。
查看
